Hjem › Blærekreft › Kansas › Kansas City
Kliniske studier for Blærekreft i Kansas City, KS
12 studier for Blærekreft søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RekruttererFase 2
- University of Kansas Cancer Center, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi unna
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RekruttererFase 1
- The University of Kansas Hospital Cambridge North Tower A, Kansas City
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- University of Kansas Cancer Center, Kansas City
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- The University of Kansas Cancer Center, Kansas City
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- University of Kansas Medical Center, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
- University of Kansas Hospital Cambridge North Tower A, Kansas City
- og 1 flere
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
- University of Kansas Medical Center, Kansas City
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Blue Light Cystoscopy With Cysview® Registry
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
RekruttererFase 2
- The University of Kansas Cancer Center, Kansas City
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andre studier i Kansas City
- Kardiovaskulær sykdom14 studier
- Hjertesvikt13 studier
- Fedme13 studier
- Interstitielle lungesykdommer13 studier
- Cystisk fibrose13 studier
- Brystkreft12 studier
- Akut myelogen leukemi12 studier
- Prostatakreft12 studier
- Ikke-småcellet lungekreft11 studier
- Lungekreft11 studier
- KOLS9 studier
- Astma8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.